Anna Baghdasaryan

Medical University of Graz — Austria

Medicine · Health Sciences

11h-index970citations37works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(14), Pediatric Hepatobiliary Diseases and Treatments(10), Liver Disease Diagnosis and Treatment(9), Liver Diseases and Immunity(7), Clinical Nutrition and Gastroenterology(3)

Publications37 total

The genotypic and phenotypic landscape of <i>PDHA1</i> -related pyruvate dehydrogenase complex deficiency
Brain·2025Open Access
Hearing rehabilitation in SERAC1 related MEGD(H)EL syndrome – implications from a multi-center retrospective cohort study
Molecular Genetics and Metabolism·2025· 1 citedOpen Access
The Benefit of Detecting Reduced Intracellular B12 Activity through Newborn Screening Remains Unclear
International Journal of Neonatal Screening·2024· 1 citedOpen Access
Hearing Rehabilitation in Patients with SERAC1 Related MEGD(H)EL Syndrome
2023Open Access
Histological demonstration of BSEP/ABCB11 inhibition in transient neonatal cholestasis: a case report
BMC Pediatrics·2020· 3 citedOpen Access
Behandling av långvarig smärta med etoricoxib
2017
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis
Journal of Hepatology·2015· 181 citedOpen Access
Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis
Zeitschrift für Gastroenterologie·2015· 1 cited
P389 PROTECTIVE ROLE OF MEMBRANE BILE ACID RECEPTOR TGR5 (GPBAR1) IN DDC-INDUCED SCLEROSING CHOLANGITIS IN MICE
Journal of Hepatology·2014· 4 cited
O135 INHIBITION OF INTESTINAL BILE ACID ABSORPTION BY ASBT INHIBITOR A4250 PROTECTS AGAINST BILE ACID-MEDIATED CHOLESTATIC LIVER INJURY IN MICE
Journal of Hepatology·2014· 5 cited
Clinical application of transcriptional activators of bile salt transporters
Molecular Aspects of Medicine·2013· 53 citedOpen Access
Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia
Hepatology·2013· 98 citedOpen Access
Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
Clinics in Liver Disease·2013· 98 citedOpen Access
16 Bile acids and receptors: Therapeutic relevance
2012
Falk Symposium Series
Digestive Diseases·2012Open Access
Front &amp; Back Matter
Digestive Diseases·2012
Primary Sclerosing Cholangitis: New Approaches to Diagnosis, Surveillance and Treatment
Digestive Diseases·2012· 19 cited
Author Index Vol. 30, Suppl. 1, 2012
Digestive Diseases·2012Open Access
Title Page / Table of Contents
Digestive Diseases·2012Open Access
Farnesoid X receptor represses hepatic human APOA gene expression
Journal of Clinical Investigation·2011· 113 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Michael Trauner(36), Peter Fickert(30), Thierry Claudel(21), Emina Halilbasic(17), Tarek Moustafa(17), Druck Reinhardt Druck Basel(14), Gernot Zollner(11), Michael P. Manns(10), J. Gumhold(8), Dagmar Silbert(8), Elisabeth Krones(7), Elmar Jaeckel(7), Christian P. Strassburg(7), Heiner Wedemeyer(7), Tom H. Karlsen(7), Christopher P. Day(7), Satz Mengensatzproduktion(7), Catherine Williamson(6), Ronald P.J. Oude Elferink(6), Ulrich Beuers(6)